{"name":"IRCCS Istituto delle Scienze Neurologiche di Bologna","slug":"irccs-istituto-delle-scienze-neurologiche-di-bologna","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"MED ON plus","genericName":"MED ON plus","slug":"med-on-plus","indication":"Relapsing-remitting multiple sclerosis","status":"marketed"}]}],"pipeline":[{"name":"MED ON plus","genericName":"MED ON plus","slug":"med-on-plus","phase":"marketed","mechanism":"MED ON plus is a medication used to treat multiple sclerosis.","indications":["Relapsing-remitting multiple sclerosis","Active secondary progressive multiple sclerosis"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTFAtTmVXcjkwRmtFZjBKcWF5ZWNyMFh5b2U5SlBReUN6UE1MTERDcVFDM25FcThsMDZTWkZNdTFlTVpGNk15N2t0SXlEWHJ1TldwTVY2c1RMZnl3UUNSZVZwbk5kSlQ1bHllaUE?oc=5","date":"2026-02-26","type":"pipeline","source":"Neurology® Journals","summary":"Low Prevalence and Inconsistency of LRP4-IgG Detection in Suspected Myasthenia Gravis - Neurology® Journals","headline":"Low Prevalence and Inconsistency of LRP4-IgG Detection in Suspected Myasthenia Gravis - Neurology® Journals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNTHo4T3EyZlBCdGxlZjJtRl9DaWpMNWNfd0hLbGRvN2JQcERYcThMOHlBN1VvYVBwcDFrbjBMcjdfQ25fSWFsX0tIb3V0MUN2aVJWTVY3OE1pWmtmT1ZiZTc0X3JEMEgweHJMT3o1NV9vNWFQZ25PQ2ZtLWdoT0tUa0VUYWdXSWNJc25zXzV0N2lHNl9CTWhrX2duTkNRbk5DanJEeUVYVjNFWUJvMVZBQmZJelNvZUZsYWhTUw?oc=5","date":"2025-08-05","type":"regulatory","source":"European Medical Journal","summary":"Editor’s Pick: Precision Medicine in Neurology: Advancing Care for Female Patients - European Medical Journal","headline":"Editor’s Pick: Precision Medicine in Neurology: Advancing Care for Female Patients","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE00UDVobUxGY3ZqbUtxSmRkUi0ycGYxbFh1ZVp0dXBMaHRsczdmTFByM21WYko3SkthWTlPOGhSNURxQlBoVmRhT0otZUhfQ2FrOHFkZ3p4RnU4WEZWR2ZR?oc=5","date":"2025-08-05","type":"pipeline","source":"nature.com","summary":"Two-step detection of Lewy body pathology via smell-function testing and CSF α-synuclein seed amplification - nature.com","headline":"Two-step detection of Lewy body pathology via smell-function testing and CSF α-synuclein seed amplification","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxOT3NQdEd6bTJONzZNanVoV0xXcmZzOWdnUHZIRGVPOUs4RkpUb1ZyekdFdHJwY0FLREd1a3dueUFEWkN3cFdxVHE1TTk2cExEdXRnNExXTV9PdGJjRTg3NEExWmdpbnFLcXpoQV9MMHg1YUQ0UWFWRkYwbVZOaDVrLXRkaXAtV19DbThoQ3FoWEczTE9WMzBEck9EU25jNWt5WlhlSjBxRHpVNF9odjRlUDB1Q1pnYm0xNTVuVTI4N0xWd0lhQWFSV1hTaWpzSlh1RFhVNkVfRGRFM1EwUm0zcFlXNjVNWFQxQXpwSkFLbXJicnktd2RlcQ?oc=5","date":"2025-03-03","type":"pipeline","source":"Ricerca Malattie Genetiche Rare","summary":"A platform dedicated to Duchenne Muscular Dystrophy - Ricerca Malattie Genetiche Rare","headline":"A platform dedicated to Duchenne Muscular Dystrophy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE1tQ1NQMVZ5SmNBcGptcTRWMEdRRXotSjczWmxFUWd0TVhQaHRZcC1GUmhGaUh4ZHJCNHBQSExWcEItRE4zMWJ2Smw2RW01UE4wM2tXcUN6Ymw5aXUyR3c0SlFPNG1hR1RWSWc?oc=5","date":"2025-03-03","type":"pipeline","source":"Neurology® Journals","summary":"Infantile TK2 Deficiency Causing Mitochondrial Encephalomyopathy With Migrating Focal Seizures - Neurology® Journals","headline":"Infantile TK2 Deficiency Causing Mitochondrial Encephalomyopathy With Migrating Focal Seizures - Neurology® Journals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxOLXJrQTRkOTAxbjVGWGYxbngzNV92aFllemJIUnZZT2ZDWTNOenNZdFNpZHhXb2MzTGFHTFZtQURpWkp2WDZONXZFbkJPT1dBSFdIRjZqRnViWDhnbi0tOExmaXdRbjF2MXh2a1dIQWlHSjZxTGRpdllOa0d3cUE3ckRhWEEzSW9iRjBoRTFiaXhrOE04NFplczgtcmlvcDVpT2lwbFA1SFVIamtKYnhFZ0FTVXN6SUt3dE93YXBTbFE0Z1l3MkdwRTVWWFhjb1dRb091NUFYUXFvNkFFelZ4NmRfdl80MExsRkpLY2FXWjFFN0Z2eWNkczVpOXM?oc=5","date":"2024-08-13","type":"trial","source":"European Medical Journal","summary":"Idebenone Treatment for Leber Hereditary Optic Neuropathy: Time to Clinically Relevant Recovery in the LEROS Study - European Medical Journal","headline":"Idebenone Treatment for Leber Hereditary Optic Neuropathy: Time to Clinically Relevant Recovery in the LEROS Study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5SMEtBRjh5d0tvb0hxMHUxaUh0NG13QzVmOUg1dE90ZXQyTXlKTHZobFNjQ19tZUQzbmtZWmYzU2szUFFwbFZKSVZfODI3bFdHX3k3dVRReDZ0YXVfTzdB?oc=5","date":"2024-06-04","type":"trial","source":"nature.com","summary":"Multiparametric MRI dataset for susceptibility-based radiomic feature extraction and analysis | Scientific Data - nature.com","headline":"Multiparametric MRI dataset for susceptibility-based radiomic feature extraction and analysis | Scientific Data","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE5ZZVJ0MFBCUGdDTndiNzY0R3FDakRRWXhDUThKR2FQUWNUT2plTHdGdnMyZVRUdVVuNlF4a0Q2VmV0OHpvb2dvMkE1MXoyaW9lVGNIeVdqQWpnSFl2RnJMMXJNWmJYVmpwTmc?oc=5","date":"2023-12-12","type":"pipeline","source":"Neurology® Journals","summary":"Stridor in multiple system atrophy - Neurology® Journals","headline":"Stridor in multiple system atrophy - Neurology® Journals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE5pWnJubkRKWVBfUnYzemhQb0IxeWpPUXZhRk9NcXBiWlhPMlNkYXVmV3d5cm9XcDBpeS1RRzEyX0hETWVDTU5Hak9IaktucmdaQmxQNndXMkdhNTNnMXJ2NTVzMUVZZldHNXc?oc=5","date":"2023-12-10","type":"pipeline","source":"Neurology® Journals","summary":"Definition and diagnostic criteria of sleep-related hypermotor epilepsy - Neurology® Journals","headline":"Definition and diagnostic criteria of sleep-related hypermotor epilepsy - Neurology® Journals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5PQUsxNmtkeDNyN1A3Qk9Ld3l2WXJ3MG5TTlB0eDI5UUlMY002T1VXaHpZMGRnc3dKVFVJWEQxcF93eHVOaGc2Mnk0ZnFSaUFEM1VUdk1BeS14N1AwMk80?oc=5","date":"2023-09-27","type":"pipeline","source":"nature.com","summary":"Assessing robustness of quantitative susceptibility-based MRI radiomic features in patients with multiple sclerosis - nature.com","headline":"Assessing robustness of quantitative susceptibility-based MRI radiomic features in patients with multiple sclerosis","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}